Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cellsin vivo
- 1 June 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (6), 1031-1035
- https://doi.org/10.1002/eji.1830190612
Abstract
It has been shown in the mouse that cultured keratinocyte allografts [fully major histocompatibility complex (MHC) mismatched] survive for at least 100 days without evidence of rejection. In an attempt to analyze the immune mechanisms underlying this phenomenon we have investigated the induction of tolerance to such grafts. Primary cultures of BALB/c keratinocytes were prepared using irradiated 3T3 feeder cells, and the cultured cell sheets were grafted, using a silicone transplantation chamber, onto CBA recipients. After the cultured grafts had been in place for 4–6 weeks full‐thickness tail skin from BALB/c donors was grafted onto the dorsal flank opposite the cultured graft. The median graft survival time of these full‐thickness allografts was 15.5 days compared to 13 days in the control group. These data show that in the absence of Langerhans cells and MHC class II expression, keratinocytes expressing class I and minor histocompatibility antigens induce a prolonged survival of full‐thickness skin allografts. The results from experiments in which T cell subsets were depleted in vivo suggest that CD8+ cells (a) recognize the class I alloantigens of the cultured graft, (b) do not reject the cultured graft and (c) do not progress further in their maturation pathway. We propose that these CD8+ T cells might have been partially primed by receiving only the first signal of activation and that they may be equivalent to ‘poised’ cytotoxic T cells. These CD8+ cells can reject non cultured full‐thickness skin grafts, and do so more effectively after removing CD4+ cells.This publication has 27 references indexed in Scilit:
- PROLONGED SURVIVAL OF CULTURED KERATINOCYTE ALLOGRAFTS IN THE NONIMMUNOSUPPRESSED MOUSETransplantation, 1987
- Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell culturesClinical Immunology and Immunopathology, 1986
- Permanent Coverage of Large Burn Wounds with Autologous Cultured Human EpitheliumNew England Journal of Medicine, 1984
- Loss of HLA-DR Expression by Human Epidermal Cells After Growth in CultureJournal of Investigative Dermatology, 1984
- GRAFTING OF BURN PATIENTS WITH ALLOGRAFTS OF CULTURED EPIDERMAL CELLSThe Lancet, 1983
- Cultured Human Epidermal Cells Do Not Synthesize HLA-DRJournal of Investigative Dermatology, 1982
- GRAFTING OF BURNS WITH CULTURED EPITHELIUM PREPARED FROM AUTOLOGOUS EPIDERMAL CELLSThe Lancet, 1981
- Design of an artificial skin. I. Basic design principlesJournal of Biomedical Materials Research, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunityProceedings of the Royal Society of London. B. Biological Sciences, 1954